EUVIMEDEUVIMED entdecken
Crossref

Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery

Seyedeh Negin Kassaee, Amir Nili-Ahmadabadi, Mohammad Mehdi Mahboobian

Journal of Bioactive and Compatible Polymers · 2023-07 · 38 (4) · 298-310

DOI: 10.1177/08839115231167587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bioactive and Compatible Polymers, online erschienen am 24.04.2023. Verfasst von Seyedeh Negin Kassaee und 2 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Hamadan University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to develop and investigate besifloxacin (BSF) in situ gel nanoemulsions (NEs) consisting of two hydrophilic polymers, that is, poloxamer 407 (P407) and poloxamer 188 (P188), for ocular delivery. BSF loaded in situ gel-NEs containing triacetin (oil), Cremophor ® RH 40 (surfactant), Transcutol ® P (co-surfactant), poloxamer 407 and poloxamer 188 (gelling agents) were prepared by spontaneous emulsification method. The optimum in situ gel nanoemulsion was selected based on gelation temperature. The selected formulation was evaluated for physicochemical characteristics, including droplet size, refractive index, pH, transparency, and viscosity. Further investigations such as in vitro drug release, ex vivo corneal permeation, HET-CAM, pre-corneal residence time antibacterial efficacy studies were conducted too. Developed BSF in situ gel nanoemulsion showed acceptable physicochemical properties with a nano-metric droplet size of 19 nm and PDI of 0.21. Moreover, In vitro release studies revealed that the in situ gel formulation could sustain drug release as only 40% of the BSF was released within 1 h. Permeability coefficient (Papp) of BSF through the excised bovine cornea was found 6.01 × 10 −6 cm/s during 6 h. In addition, the HET-CAM evaluation confirmed the non-irritancy of the optimum BSF in situ gel NEs. The pre-corneal residence time evaluation indicated prolonged retention of in situ gel-NEs on the eye surface. Finally, antibacterial susceptibility investigations illustrated remarkable efficacy against Pseudomonas aeruginosa and Staphylococcus aureus. The current findings demonstrated that this proposed BSF-loaded in situ gel-NEs could be considered as a potential novel drug delivery formulation against ophthalmic bacterial infections.

Förderung

  • Hamadan University of Medical Sciences

Zitieren

APA

Kassaee, S. N., Nili-Ahmadabadi, A., & Mahboobian, M. M. (2023). Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery. Journal of Bioactive and Compatible Polymers, 38(4), 298-310. https://doi.org/10.1177/08839115231167587

Vancouver

Kassaee SN, Nili-Ahmadabadi A, Mahboobian MM. Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery. Journal of Bioactive and Compatible Polymers. 2023;38(4):298-310. doi:10.1177/08839115231167587

BibTeX
@article{Kassaee2023,
  author = {Kassaee, Seyedeh Negin and Nili-Ahmadabadi, Amir and Mahboobian, Mohammad Mehdi},
  title = {Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery},
  journal = {Journal of Bioactive and Compatible Polymers},
  year = {2023},
  volume = {38},
  number = {4},
  pages = {298--310},
  doi = {10.1177/08839115231167587}
}
Kostenlos starten →